Keros Therapeutics, a biotech currently engaged in a public fight with one of its largest shareholders over the future ...

A startup seeking to replace animal testing with a sophisticated high-tech platform has raised $40 million to develop ...

In 2015, doctors who attended the top 20 ranked medical schools had 52% lower odds of going on to practice in ...

In today's Pharmalittle roundup, we're reading about HHS canceling a Moderna contract, FDA rejecting a rare disease drug, and ...

Instead of approving Stealth BioTherapeutics' drug for Barth syndrome, the FDA withheld its endorsement, but decided it may ...

We are squandering trillions of dollars, often to the detriment of our patients, merely to push a number across some ...

Radiologists interpret more than 40 million mammograms in the United States every year. In 2025, AI tools to help detect or ...

HHS has notified Moderna that it is canceling a nearly $600 million contract for vaccines for flu strains that could trigger ...

General Medicine, launched by three former Amazon employees has a business model that could compete with Amazon’s One Medical ...

The recent dismissal of 13 FDA review staff eliminated precisely the kind of government spending that delivered the most bang ...

HHS Secretary Robert F. Kennedy Jr. announced that he has unilaterally struck the recommendation that healthy children and ...

Amid a measles outbreak that's the nation's largest in more than two decades, Texas is poised to make vaccine exemptions for ...